Dimerix

Dimerix Treasury Stock

The Treasury Stock of Dimerix (DXB.AX) as of Oct 11, 2026 is -3.39 M AUD. In the previous year, Treasury Stock was -12.60 M AUD — a change of -73.10% (higher).

Treasury Stock

-3.39 MAUD

YoY

-73.10%

Last updated:

Treasury Stock of Dimerix is 2023 -3.39 M AUD. Treasury Stock of Dimerix was 2022 -12.60 M AUD. It decreases by -73.10% higher compared to the previous year.

The Dimerix Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2016
299,706.00 AUD
Jan 1, 2017
352,566.00 AUD
Jan 1, 2018
625,985.00 AUD
Jan 1, 2019
669,627.00 AUD
Jan 1, 2020
-6.91 M AUD
Jan 1, 2021
-581,547.00 AUD
Jan 1, 2022
-12.60 M AUD
Jan 1, 2023
-3.39 M AUD
The Dimerix Treasury Stock history
YEARTreasury StockYoY
-3.39 MAUD-73.10%
-12.60 MAUD+2,066.12%
-581,547.00AUD-91.58%
-6.91 MAUD-1,131.66%
669,627.00AUD+6.97%
625,985.00AUD+77.55%
352,566.00AUD+17.64%
299,706.00AUD—
Access this data via the Eulerpool API
Get Free API Key

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Treasury Stock of Dimerix is -3.39 M AUD in 2023.

Treasury Stock of Dimerix changed from -12.60 M AUD to -3.39 M AUD, representing a -73.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Dimerix since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Dimerix historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Dimerix

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Dimerix